Hematopoietic Stem Cells Market

Hematopoietic Stem Cells Market contains market size and forecasts of Hematopoietic Stem Cells (HSCs) in Global, including the following market information:

• Global Hematopoietic Stem Cells (HSCs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Hematopoietic Stem Cells (HSCs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Leukocyte Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hematopoietic Stem Cells (HSCs) include Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd. and TiGenix N.V., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hematopoietic Stem Cells (HSCs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hematopoietic Stem Cells (HSCs) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hematopoietic Stem Cells (HSCs) Market Segment Percentages, by Type, 2021 (%)

• Leukocyte
• Lymphocytes
• Red Blood Cells
• Platelets

Global Hematopoietic Stem Cells (HSCs) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hematopoietic Stem Cells (HSCs) Market Segment Percentages, by Application, 2021 (%)

• Blood System Diseases
• Autoimmune Diseases
• Other

Global Hematopoietic Stem Cells (HSCs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hematopoietic Stem Cells (HSCs) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Hematopoietic Stem Cells (HSCs) revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Hematopoietic Stem Cells (HSCs) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Kite Pharma Inc.
• Thermo Fisher Scientific
• PromoCell
• CellGenix Technologie Transfer GmbH
• Cesca Therapeutics Inc.
• R&D Systems
• Genlantis
• Lonza Group Ltd.
• TiGenix N.V.
• ScienCell Research Laboratories
• China Cord Blood Corporation
• Vcanbio
• Boyalife
• Beike Biotechnology